Mendota Financial Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-33
Closed -$2.7K – 260
2024
Q4
$2.7K Sell
33
-1
-3% -$83 ﹤0.01% 280
2024
Q3
$2.81K Buy
34
+1
+3% +$75 ﹤0.01% 298
2024
Q2
$2.32K Hold
33
– – ﹤0.01% 274
2024
Q1
$2.45K Hold
33
– – ﹤0.01% 277
2023
Q4
$2.18K Hold
33
– – ﹤0.01% 317
2023
Q3
$2.08K Hold
33
– – ﹤0.01% 249
2023
Q2
$1.87K Hold
33
– – ﹤0.01% 250
2023
Q1
$2.32K Hold
33
– – ﹤0.01% 276
2022
Q4
$2.39K Buy
+33
New +$2.36K ﹤0.01% 257

Other funds holding MET

Mendota Financial Group's MET Position: Q1 2025 in Review

Mendota Financial Group sold out of MetLife (MET) in Q1 2025, closing a stake of 33 shares — an estimated $2.7K sold.

Mendota Financial Group first reported a position in MET in Q4 2022 and held it in 9 quarters. The position peaked at $2.81K in Q3 2024. 1,411 funds tracked by Wall St. Rank hold MET as of Q1 2025.

  • Mendota Financial Group reported no remaining MetLife position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 33 MetLife shares in Q1 2025, an estimated $2.7K.
  • Mendota Financial Group first reported a position in MetLife in Q4 2022 and held it in 9 quarters.
  • Mendota Financial Group's MetLife position peaked at $2.81K in Q3 2024.
  • 1,411 funds tracked by Wall St. Rank held MetLife as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.